MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
84.67%
Quick Ratio
84.67%
Cash Ratio
56.37%
Debt to Asset Ratio
47.25%
Unit: Thousand (K) dollars
Assets Breakdown
    • In-process research and developm...
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
761
2,398
3,999
5,435
Restricted cash security deposit
50
50
50
50
Prepaid expenses and other current assets
332
367
26
168
Total current assets
1,143
2,815
4,075
5,653
Leasehold improvements and equipment net
-
138
138
156
Assets held for sale - net
-
-
-
70
Operating lease right-of-use assets net
6
457
531
1,351
Finance lease right-of-use assets net
3
4
4
5
In-process research and development
2,260
2,260
2,260
2,260
Restricted cash security deposit
-
200
200
200
Total non-current assets
2,269
3,059
3,133
4,042
Total assets
3,412
5,874
7,208
9,695
Accounts payable
845
712
315
80
Accrued expenses
504
694
452
564
Operating lease liabilities current
-
718
694
846
Financing lease liabilities current
1
2
2
5
Total current liabilities
1,350
2,126
1,463
1,495
Deferred tax liability
257
257
257
257
Operating lease liabilities net of current portion
-
464
653
1,472
Financing lease liabilities net of current portion
5
5
5
11
Total non-current liabilities
262
726
915
1,740
Total liabilities
1,612
2,852
2,378
3,235
Common stock par value 0.0001 per share, 500,000,000 shares authorized at june 30, 2026 and december 31, 2025 6,406,191 issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
1
1
1
1
Additional paid-in capital
215,833
215,729
215,616
215,334
Accumulated deficit
-214,034
-212,708
-210,787
-208,875
Total stockholders equity
1,800
3,022
4,830
6,460
Total liabilities and stockholders equity
3,412
5,874
7,208
9,695
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

In-process research anddevelopment$2,260K (0.00%↑ Y/Y)Operating leaseright-of-use assets net$6K (-99.59%↓ Y/Y)Finance leaseright-of-use assets net$3K (-50.00%↓ Y/Y)Cash and cashequivalents$761K (-88.34%↓ Y/Y)Prepaid expenses andother current assets$332K (-52.09%↓ Y/Y)Restricted cash securitydeposit$50K (0.00%↑ Y/Y)Total non-currentassets$2,269K (-45.40%↓ Y/Y)Total current assets$1,143K (-84.27%↓ Y/Y)Total assets$3,412K (-70.13%↓ Y/Y)Total liabilities andstockholders equity$3,412K (-70.13%↓ Y/Y)Total stockholdersequity$1,800K (-76.55%↓ Y/Y)Total liabilities$1,612K (-57.00%↓ Y/Y)Accumulated deficit-$214,034K (-3.54%↓ Y/Y)Additional paid-in capital$215,833K (0.67%↑ Y/Y)Total currentliabilities$1,350K (-24.33%↓ Y/Y)Total non-currentliabilities$262K (-86.67%↓ Y/Y)Common stock par value0.0001 per share,...$1K (0.00%↑ Y/Y)Accounts payable$845K (405.99%↑ Y/Y)Accrued expenses$504K (-36.60%↓ Y/Y)Financing leaseliabilities current$1K (-80.00%↓ Y/Y)Deferred tax liability$257K (0.00%↑ Y/Y)Financing leaseliabilities net of current...$5K (-54.55%↓ Y/Y)

Matinas BioPharma Holdings, Inc. (MTNB)

Matinas BioPharma Holdings, Inc. (MTNB)